Effectiveness of Treatments That Alter Metabolomics in Cancer Patients—A Systematic Review
Introduction: Cancer is the leading cause of death worldwide, with the most frequent being breast cancer in women, prostate cancer in men and colon cancer in both sexes. The use of metabolomics to find new biomarkers can provide knowledge about possible interventions based on the presence of oncomet...
Main Authors: | Santiago Navarro Ledesma, Dina Hamed-Hamed, Ana González-Muñoz, Leo Pruimboom |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-08-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/15/17/4297 |
Similar Items
-
Microbiome, Mycobiome and Related Metabolites Alterations in Patients with Metabolic Syndrome—A Pilot Study
by: Gratiela Gradisteanu Pircalabioru, et al.
Published: (2022-02-01) -
Alterations of bacteriome, mycobiome and metabolome characteristics in PCOS patients with normal/overweight individuals
by: Guoshu Yin, et al.
Published: (2022-10-01) -
Machine Learning Applied to Omics Datasets Predicts Mortality in Patients with Alcoholic Hepatitis
by: Bei Gao, et al.
Published: (2022-01-01) -
Altered gut mycobiome in patients with end-stage renal disease and its correlations with serum and fecal metabolomes
by: Yi Ren, et al.
Published: (2024-02-01) -
Childhood Obesity and the Cryptic Language of the Microbiota: Metabolomics’ Upgrading
by: Alice Bosco, et al.
Published: (2023-03-01)